CEO's On the Move

Monash IVF Group Ltd. Announces the Appointment of David Morris as Chief Executive Officer and Managing Director, Effective 13 November 2017
10/17/2017
Monash IVF Group Limited (MVF:AU:Australian Stock Exchange - SEATS) Monash IVF Group Ltd. announced the appointment of Mr. David Morris as the CEO and MD, effective 13 November 2017. David has more than 20 years of leadership, international business development and strategy experience. Over his 13 years at Cochlear Limited, David served as Chief Strategy Officer, having ...

Upcoming Board Meetings

Localiza Rent a Car S.A.
(RENT3:BZ:Sao Paulo Stock Exchange)
October 19, 2017
Localiza Rent a Car S.A., Board Meeting, Oct 19, 2017. Agenda: To consider analysis and follow up of the monthly results; and to consider and approve third quarter of 2017 interim financial information.
Announced 06/28/17
Localiza Rent a Car S.A. Key Board Members
José Mattar
Chairman of the Board
Eugenio Mattar
Chief Executive Officer and Executive Director
Antônio Resende
Deputy Chairman

Executive Changes

Royal Dutch Shell plc Announces Guy Elliott Stood Down as Non-Executive Director
10/18/17
Royal Dutch Shell plc announced that Guy Elliott has stood down as a Non-executive Director of the company with immediate effect.
Gaming Realms plc Announces Appointment of Chris Bell as Non-Executive Director
10/18/17
Gaming Realms plc announced the appointment of Chris Bell as a Non-Executive Director. He joins the Board with immediate effect. Prior to joining Hilton Group, he held several senior positions at drinks manufacturer Allied Domeq. He is currently Chairman of XLMedia Plc and TechFinancials Inc. and the Senior Independent Director of The Rank Group Plc.
Tissue Regenix Group plc Announces Executive Changes
10/18/17
The board of Tissue Regenix Group plc announced that Antony Odell, Chief Executive Officer (CEO), will be stepping down from his role and position on the Board with immediate effect. The Board will commence a process for appointment of a new CEO. In the interim, John Samuel, Non- Executive Chairman has assumed the role of Executive Chairman.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Top Compensated Executives at MVF:AU

Name/TitleAnnual Compensation
Benjamin ThiedemanA$510.1K
CEO, MD & Executive Director
Michael KnaapA$394.3K
CFO & Company Secretary
Richard HenshawA$376.0K
Executive Director
Michelle LaneA$139.2K
Regional Manager
Compensation as of Fiscal Year 2017. All Compensation is in USD.

Average Compensation in the Biotechnology Industry

Biotechnology
$486.7K
Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.